When do performance-based risk-sharing arrangements make sense?

European Journal of Health Economics

Volumn 16, Issue 6, 2015, Pages 569-571

  Drummond, Michael ^a  

^a UNIVERSITY OF YORK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BORTEZOMIB; M PROTEIN;

CLINICAL EFFECTIVENESS; COST EFFECTIVENESS ANALYSIS; DATA ANALYSIS; EDITORIAL; HEALTH CARE COST; HEALTH CARE MANAGEMENT; HEALTH CARE PERSONNEL; HEALTH CARE QUALITY; HUMAN; INFORMATION PROCESSING; MULTIPLE MYELOMA; OUTCOME ASSESSMENT; PERFORMANCE BASED RISK SHARING ARRANGEMENT; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REIMBURSEMENT; RISK MANAGEMENT; BIOMEDICAL TECHNOLOGY ASSESSMENT; ORGANIZATION AND MANAGEMENT; PROCEDURES; TIME; UNCERTAINTY;

DATA COLLECTION; HUMANS; REIMBURSEMENT, INCENTIVE; RISK SHARING, FINANCIAL; TECHNOLOGY ASSESSMENT, BIOMEDICAL; TIME FACTORS; UNCERTAINTY;

EID: 84930865466     PISSN: 16187598     EISSN: 16187601     Source Type: Journal    
DOI: 10.1007/s10198-015-0683-z     Document Type: Editorial

References (8)

1. Hutton, J., Trueman, P., Henshall, C.: Coverage with evidence development: an examination of conceptual and policy issues. Int J Tech Assess Health Care 23, 425–435 (2007)
2. Adamski, J., Godman, B., Ofierska-Sujkowska, G., et al.: Risk sharing arrangements for pharmaceuticals: potential considerations and recommendations for European payers. BMC Health Serv Res 10, 153–169 (2010)
3. Garrison, L.P., Towse, A., Briggs, A., et al.: Performance-based risk-sharing arrangements- Good practices for design, implementation and evaluation: report of the ISPOR good research practices for performance-based risk-sharing arrangements task force. Value Health 16, 703–719 (2013)
4. Neumann, P.J.: Where are we on ‘risk-sharing’ arrangements? Value Health 16, 701–702 (2013)
5. Raftery, J.: Multiple sclerosis risk sharing scheme: a costly failure. Br Med J (2010). doi:10.1136/bmj.c1786
6. Ciani, O., Davies, S., Tappenden, P., et al.: Validation of surrogate endpoints in advanced solid tumors: systematic review of statistical methods, results, and implications for policy makers. Int J Tech Assess Health Care 30, 312–324 (2014)
7. Edlin, R., Hall, P., Wallner, K., McCabe, C.: Sharing risk between payer and provider by leasing health technologies: an affordable and effective reimbursement strategy for innovative technologies? Value Health 17, 438–444 (2014)
8. Levin, L., Goeree, R., Sikich, N., et al.: Establishing a comprehensive continuum from an evidentiary base to policy development for health technologies: the Ontario experience. Int J Tech Assess Health Care 23(3), 299–309 (2007)